SYDNEY, Australia, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced the ...

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) will host an online webinar on March 19, 2026, as the company updates investors on progress across its anti-infective portfolio. The webinar will be held ...

Story: In his maiden investigation, sub-inspector Lenin (Sri Ram) is tasked to solve a dual murder case in Tadipatri village in 1992. His quest takes him to the dark corners of familial relationships ...

Recce Pharmaceuticals targets Recce targets Middle East expansion with 10-year R327G licensing deal Proactive uses images sourced from Shutterstock Expansion into the Middle East and North Africa ...

Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF) has strengthened its intellectual property position in Southeast Asia after securing a Vietnamese patent covering its RECCE® 327 and RECCE® 529 ...

Recce’s R327G highly effective against methicillin-resistant Staphylococcus aureus and Pseudomonas aeruginosa infected wounds (in-vivo) R327G efficacy outcomes statistically significant and ...

Recce, a new film & TV recommendation app designed to cure content overload and bring clarity to viewer decision fatigue, has launched. With an intuitive interface, and a community centric approach, ...

A$5.0 million commitment received from Australian-based private investor A$10.8 million Entitlement Offer at the same offer price as the placement Funds to support Phase III Topical clinical trials in ...

Expansion into the Middle East and North Africa (MENA) region is now firmly in Recce Pharmaceuticals Ltd (ASX:RCE, OTC:RECEF)'s sights after it took a step toward commercialising its R327 Topical Gel, ...